Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Journal of Virology|April 13, 2018
HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the ProteasomeSekar Natesampillai, Nathan W Cummins, Zilin Nie, et al.AIDS (London, England)|December 28, 2013
Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohortJason V Baker, Katherine Huppler Hullsiek, Amrit Singh, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102Keith Henry, David Katzenstein, Deborah Weng Cherng, et al.The Journal of Biological Chemistry|September 3, 2014
Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding siteRejwi Acharya Dahal, Akula Bala Pramod, Babita Sharma, et al.The Journal of Infectious Diseases|February 17, 2018
Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN StudyErna Milunka Kojic, Lois Conley, Tim Bush, et al.AIDS Patient Care and Stds|December 4, 2012
Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United StatesEllen M Tedaldi, Mary van den Berg-Wolf, James Richardson, et al.The Journal of Infectious Diseases|May 13, 2014
Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infectionEleanor M P Wilson, Amrit Singh, Katherine Huppler Hullsiek, et al.AIDS Research and Human Retroviruses|October 13, 2005
A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087Judith A Aberg, Robert A Zackin, Susan W Brobst, et al.AIDS Research and Human Retroviruses|September 15, 2015
High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral TherapyGerome V Escota, Kristin Mondy, Tim Bush, et al.AIDS (London, England)|February 11, 2014
Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adultsCalvin Cohen, David Wohl, Jose R Arribas, et al.Pageof 13